Elite Pharmaceuticals (ELTP) Non-Current Deffered Revenue (2011 - 2024)
Elite Pharmaceuticals' Non-Current Deffered Revenue came in at $2,222 for fiscal Q1 2025 (quarter ended Jun 30, 2024), down 85.7% from $15,556 a year earlier and down 60.0% from the prior quarter.
Powered by 
Analysis
Elite Pharmaceuticals (ELTP) Non-Current Deffered Revenue (2011 - 2024) Analysis & Trends
At the end of FY2024 (ended Mar 31, 2024), Elite Pharmaceuticals' Non-Current Deffered Revenue was $5,556, down 70.6% from FY2023.
- Non-Current Deffered Revenue has declined in each of the last eight fiscal years, with a five-year compound annual growth rate of -52.9% (FY2019 to FY2024).
- Going back by fiscal year, Non-Current Deffered Revenue was $18,890 in FY2023 (-41.4%), $32,226 in FY2022 (-29.3%), $45,558 in FY2021 (-22.6%) and $58,891 in FY2020 (-75.3%).
- The fiscal Q1 2025 figure represents the lowest quarterly Non-Current Deffered Revenue in data going back to fiscal Q4 2011.
- Year-over-year, Non-Current Deffered Revenue has declined for four consecutive quarters, with an average decline of 54.5% over the last seven quarters.
- The year-over-year decline in Non-Current Deffered Revenue has ranged between 10.7% (fiscal Q3 2021) and 91.2% (fiscal Q2 2020) over the last five years.
- Business Quant data shows ELTP's Non-Current Deffered Revenue at $5,556 (Q4 2024), $8,889 (Q3 2024) and $12,222 (Q2 2024) in the three fiscal quarters before Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | - |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Elite Pharmaceuticals | 268.12 Mn | 149.80 Mn | 13.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2024 | 2,222.00 |
| Mar 31, 2024 | 5,556.00 |
| Dec 31, 2023 | 8,889.00 |
| Sep 30, 2023 | 12,222.00 |
| Jun 30, 2023 | 15,556.00 |
| Mar 31, 2023 | 18,890.00 |
| Dec 31, 2022 | 22,223.00 |
| Sep 30, 2022 | 25,556.00 |
| Mar 31, 2022 | 32,226.00 |
| Dec 31, 2021 | 35,559.00 |
| Sep 30, 2021 | 38,892.00 |
| Jun 30, 2021 | 42,225.00 |
| Mar 31, 2021 | 45,558.00 |
| Dec 31, 2020 | 55,558.00 |
| Sep 30, 2020 | 55,558.00 |
| Jun 30, 2020 | 55,558.00 |
| Mar 31, 2020 | 58,891.00 |
| Dec 31, 2019 | 62,224.00 |
| Sep 30, 2019 | 65,557.00 |
| Jun 30, 2019 | 68,890.00 |
API Access
Elite Pharmaceuticals Non-Current Deffered Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ELTP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-deffered-revenue", "ticker": "ELTP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=ELTP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();